Skip to content

Psoriasis Health Center

Font Size

New Skin Cream Approved for Psoriasis

Taclonex Combines 2 Psoriasis Drug Treatments

WebMD Health News
Reviewed by Louise Chang, MD

Jan. 13, 2006 -- The FDA has approved the first skin cream to combine two popular psoriasis therapies in a single, once-a-day treatment.

More than 4.5 million people suffer from psoriasis, which is a chronic skin disease that can cause patches of itchy, scaly, and inflamed skin. It is not a contagious disease. Although there isn't a cure for the disease, several treatments can keep it under control.

Taclonex combines two widely used psoriasis treatments: a corticosteroid to treat inflammation and a form of vitamin D to control cell growth.

The FDA based its approval on studies that showed the skin cream significantly improved mild to severe cases of psoriasis.

Taclonex was developed in Denmark in 2001 and has been used in 63 countries under the names Dovobet and Daivobet.

Warner Chilcott will market Taclonex in the U.S. and expects to have the drug available in pharmacies by June 2006, the company says in a news release.

Today on WebMD

Woman sitting in front of UV lights
About 7.5 million people in the U.S. Get the facts.
stress and psoriasis
What might spark your psoriasis today?
woman bathing
Slideshow: Home Remedies For Psoriasis
woman applying lotion
It starts in the immune system. Read on.
Top Psoriasis Treatments To Try At Home
Woman sitting in front of UV lights
Beware Miracle Diets For Psoriasis
Psoriasis Laser Therapy
10 Questions About Psoriasis To Ask Your Doctor
psoriasis on elbow
Psoriasis (Moderate to Severe)
Psoriatic Arthritis Do You Know The Symptoms